Skip to content

Clinical trials

Phase 3 Thrombosis trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombosis Phase: Phase 3 Country / region: South Korea Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20091
20101
20121
20141

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca1
Bayer1
Daiichi Sankyo1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Sanofi1
Yong Seog Oh1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombosis6
Pulmonary Embolism2
Stroke2
Thromboembolism2
Venous Thromboembolism2
Venous Thrombosis2
Acute Coronary Syndrome1
Arrhythmias, Cardiac1
Atrial Fibrillation1
Cardiovascular Diseases1

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.